July 2, 2020

July 02, 2020

Radiomics model IDs early-stage lung cancer patients who may need aggressive treatment

Health Imaging – July 1

Researchers from H. Lee Moffitt Cancer Center and Research Institute have harnessed the quantitative data within medical images to spot lung cancer patients who may be at higher risk for worse outcomes.


Time To Learn About The Coronavirus with Dr. Aliyah Baluch and Yanina Pasikhova

98.7 The Shark – July 1

We were put in touch with Dr. Aliyah Baluch, a member of Moffitt Cancer Center’s Infectious Disease, and she agreed to join the morning show with Yanina Pasikhova, a clinical pharmacist, from their team, to shed light on what we should know and answer our questions.


A Game of Cancer and Evolution

The Scientist Speaks Podcast – July 1

Tiffany Garbutt from The Scientist’s Creative Services team spoke with Robert Gatenby, chairman of the radiology department and co-director of the Center of Excellence for Evolutionary Therapy at the Moffitt Cancer Center, to learn more.


Crisis Generates Telehealth Boom in Florida

AARP – July 1

“A lot of providers were reluctant to jump aboard,” said Philippe Spiess, M.D., Moffitt’s medical director of virtual health. “A lot of those people are now firm believers and adopters.”


Lenzilumab Demonstrates Clinical Benefit in Patients With Chronic Myelomonocytic Leukemia

ASH Clinical Trail News – July 1

According to corresponding study author Eric Padron, MD, of the Moffitt Cancer Center in Tampa, Florida, this is the first study that evaluated neutralization of GM-CSF as a therapeutic strategy in CMML. 


40 Women Researchers Receive $40,000 in Grants from Cayman and CABRI

PR.com – July 1

Chang Jiang, PhD, Moffitt Cancer Center, USA
Laura Torrente Fernandez, PhD, Moffitt Cancer Center, USA
Paloma Gonzalez Sanchez, PhD, Moffitt Cancer Center, USA


Unleashing the Power Within Using Tumor-Infiltrating Lymphocyte Therapy

Cure – June 30

The rub: “Doctors have to deplete the patient’s immune system so that, when you infuse the TILs back into patients, they don’t have to compete against other immune cells for resources,” says Dr. Amod Sarnaik, a surgical oncologist at Moffitt Cancer Center in Tampa, Florida.


Ridge Road construction moves forward

The Laker/Lutz News – June 30

Moffitt Cancer and Research Institute recently purchased about 775 acres for a future research hub near the interchange.


Treating Mantle Cell Lymphoma: A Look At ZUMA-2 Trial And KTE-X19

OncLive – June 24

I’m Dr Bijal Shah from the Moffitt Cancer Center in Tampa, Florida. I’m an associate professor in the Department of Malignant Hematology, where I focus on the treatment of mantle cell lymphoma.


CIO moves in 2020 so far

Becker’s Hospital Review – June 30

Tampa, Fla.-based Moffitt Cancer Center named Elizabeth "Beth" Lindsay-Wood vice president and CIO.


Coronavirus Could Upend Cancer Trends in the U.S.

Time – June 29

“When you think of cancer care, there is very little that is elective,” says Dr. Robert Keenan, chief medical officer and vice president of quality at Moffitt Cancer Center in Tampa, Fl. 



The Nation’s Health – July 2020

John Cleveland, PhD, in April was appointed director and executive vice president of the Moffitt Cancer Center. Cleveland previously worked at the National Cancer Institute.


Two local companies named ‘Best Places to Work in IT’

St Pete Catalyst - June 29

Moffitt Cancer Center in Tampa and KnowBe4 in Clearwater were each named "Best Places to Work in IT" by InsiderPro and ComputerWorld. 


AUA 2020: Second Opinion Cases: Distal Penile Cancer: Options to Partial Penectomy

UroToday – June 29

Presented by: Curtis Pettaway, MD, Department of Urology, Division of Surgery, Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, Phillippe Spiess, MD, Genitourinary Oncologist, Assistant Chief of Surgical Services, Moffitt Cancer Center, R. Jeffrey Karnes, MD, Urologist, Mayo Clinic, and Karen Hoffman, MD, Associate Professor, Radiation Oncology, MD Anderson Cancer Center, Houston, Texas


How radiomics can help detect lung cancer

Lab Roots – June 27

The new technique, described by researchers at the Moffitt Cancer Center, is better adept at identifying early-stage lung cancer patients who may be at high risk for poorer outcomes. 


Combo drug improves survival in older patients with high-risk/secondary AML

MD Edge – June 26

As part of the American Society of Clinical Oncology virtual scientific program, Jeffrey E. Lancet, MD, of the Moffitt Cancer Center in Tampa, Fla., presented the 5-year final data from a trial comparing CPX-351 vs. the conventional 7+3 regimen of cytarabine and daunorubicin in more than 300 older adult patients (age 60-75 years) with newly diagnosed high-risk or secondary AML.



Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.